{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:17:19Z","timestamp":1791389839048,"version":"4.3.3"},"reference-count":33,"publisher":"Elsevier BV","issue":"15","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.vaccine.2006.12.031","type":"journal-article","created":{"date-parts":[[2006,12,30]],"date-time":"2006-12-30T07:07:18Z","timestamp":1167462438000},"page":"2800-2810","source":"Crossref","is-referenced-by-count":94,"title":["Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates"],"prefix":"10.1016","volume":"25","author":[{"given":"Susan E.","family":"Sloan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathleen","family":"Hanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Weldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Niezgoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesse","family":"Blanton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Self","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirk J.","family":"Rowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Mandell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory J.","family":"Babcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"William D.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Rupprecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Ambrosino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2006.12.031_bib1","unstructured":"World Health Organization-Rabies fact sheet 99; 2005 [revised September 2005]."},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.031_bib2","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/517179","article-title":"Additional reports of failure to respond to treatment after rabies exposure in Thailand","volume":"28","author":"Hemachudha","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.031_bib3","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1093\/clinids\/22.2.228","article-title":"Failure of postexposure treatment of rabies in children","volume":"22","author":"Wilde","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.031_bib4","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/0264-410X(89)90010-8","article-title":"Failure of rabies postexposure treatment in Thailand","volume":"7","author":"Wilde","year":"1989","journal-title":"Vaccine"},{"issue":"28\u201329","key":"10.1016\/j.vaccine.2006.12.031_bib5","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1016\/S0264-410X(01)00135-9","article-title":"Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis","volume":"19","author":"Hanlon","year":"2001","journal-title":"Vaccine"},{"issue":"19","key":"10.1016\/j.vaccine.2006.12.031_bib6","doi-asserted-by":"crossref","first-page":"10537","DOI":"10.1128\/JVI.77.19.10537-10547.2003","article-title":"Glycoprotein of nonpathogenic rabies viruses is a key determinant of human cell apoptosis","volume":"77","author":"Prehaud","year":"2003","journal-title":"J Virol"},{"issue":"9","key":"10.1016\/j.vaccine.2006.12.031_bib7","doi-asserted-by":"crossref","first-page":"4552","DOI":"10.1128\/JVI.78.9.4552-4560.2004","article-title":"Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor","volume":"78","author":"Babcock","year":"2004","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.031_bib8","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S0958-1669(99)00054-3","article-title":"Advances in surface plasmon resonance biosensor analysis","volume":"11","author":"Rich","year":"2000","journal-title":"Curr Opin Biotechnol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.031_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1086\/314846","article-title":"A direct comparison of the activities of two humanized respiratory syncytial virus monoclonal antibodies: MEDI-493 and RSHZl9","volume":"180","author":"Johnson","year":"1999","journal-title":"J Infect Dis"},{"issue":"11","key":"10.1016\/j.vaccine.2006.12.031_bib10","doi-asserted-by":"crossref","first-page":"6705","DOI":"10.1128\/JVI.69.11.6705-6711.1995","article-title":"Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity","volume":"69","author":"He","year":"1995","journal-title":"J Virol"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.031_bib11","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1006\/viro.1995.1016","article-title":"Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes","volume":"206","author":"Connor","year":"1995","journal-title":"Virology"},{"issue":"17\u201319","key":"10.1016\/j.vaccine.2006.12.031_bib12","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1016\/S0264-410X(00)00516-8","article-title":"The incurable wound revisited: progress in human rabies prevention?","volume":"19","author":"Hanlon","year":"2001","journal-title":"Vaccine"},{"issue":"32","key":"10.1016\/j.vaccine.2006.12.031_bib13","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.vaccine.2005.03.037","article-title":"Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses","volume":"23","author":"Brookes","year":"2001","journal-title":"Vaccine"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.031_bib14","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.virusres.2005.03.009","article-title":"Efficacy of rabies biologics against new lyssaviruses from Eurasia","volume":"111","author":"Hanlon","year":"2005","journal-title":"Virus Res"},{"issue":"40","key":"10.1016\/j.vaccine.2006.12.031_bib15","doi-asserted-by":"crossref","first-page":"28745","DOI":"10.1074\/jbc.274.40.28745","article-title":"Enhanced expression, native purification, and characterization of CCR5, a principal HIV-1 coreceptor","volume":"274","author":"Mirzabekov","year":"1999","journal-title":"J Biol Chem"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.031_bib16","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.virol.2004.04.050","article-title":"Codon optimization of the human papillomavirus 11 (HPV 11) L1 gene leads to increased gene expression and formation of virus-like particles in mammalian epithelial cells","volume":"326","author":"Mossadegh","year":"2004","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.031_bib17","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/JVI.53.3.926-934.1985","article-title":"Rabies virulence: effect on pathogenicity and sequence characterization of rabies virus mutations affecting antigenic site III of the glycoprotein","volume":"53","author":"Seif","year":"1985","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.12.031_bib18","doi-asserted-by":"crossref","first-page":"4672","DOI":"10.1128\/JVI.79.8.4672-4678.2005","article-title":"Novel rabies virus-neutralizing epitope recognized by human monoclonal antibody: fine mapping and escape mutant analysis","volume":"79","author":"Marissen","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.031_bib19","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1073\/pnas.80.1.70","article-title":"Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus","volume":"80","author":"Dietzschold","year":"1983","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.031_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/JVI.62.1.1-7.1988","article-title":"Antigenic site II of the rabies virus glycoprotein: structure and role in viral virulence","volume":"62","author":"Prehaud","year":"1988","journal-title":"J Virol"},{"issue":"8","key":"10.1016\/j.vaccine.2006.12.031_bib21","doi-asserted-by":"crossref","first-page":"4198","DOI":"10.1128\/JVI.65.8.4198-4203.1991","article-title":"Antigenicity of rabies virus glycoprotein","volume":"65","author":"Benmansour","year":"1991","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.031_bib22","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1128\/IAI.16.3.754-759.1977","article-title":"Rabies virus glycoprotein. II. Biological and serological characterization","volume":"16","author":"Cox","year":"1977","journal-title":"Infect Immun"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.031_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1002\/jmv.10481","article-title":"Case report: isolation of a European bat lyssavirus type 2a from a fatal human case of rabies encephalitis","volume":"71","author":"Fooks","year":"2003","journal-title":"J Med Virol"},{"issue":"7","key":"10.1016\/j.vaccine.2006.12.031_bib24","doi-asserted-by":"crossref","first-page":"3268","DOI":"10.1128\/JVI.75.7.3268-3276.2001","article-title":"Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity","volume":"75","author":"Badrane","year":"2001","journal-title":"J Virol"},{"issue":"6","key":"10.1016\/j.vaccine.2006.12.031_bib25","doi-asserted-by":"crossref","first-page":"3087","DOI":"10.1128\/JVI.64.6.3087-3090.1990","article-title":"Biological characterization of human monoclonal antibodies to rabies virus","volume":"64","author":"Dietzschold","year":"1990","journal-title":"J Virol"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.031_bib26","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1172\/JCI114260","article-title":"Use of mouse anti-rabies monoclonal antibodies in postexposure treatment of rabies","volume":"84","author":"Schumacher","year":"1989","journal-title":"J Clin Invest"},{"issue":"14","key":"10.1016\/j.vaccine.2006.12.031_bib27","doi-asserted-by":"crossref","first-page":"9062","DOI":"10.1128\/JVI.79.14.9062-9068.2005","article-title":"Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants","volume":"79","author":"Bakker","year":"2005","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.031_bib28","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1006\/viro.1993.1261","article-title":"Mechanisms of rabies virus neutralization","volume":"194","author":"Flamand","year":"1993","journal-title":"Virology"},{"issue":"1","key":"10.1016\/j.vaccine.2006.12.031_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/0042-6822(87)90167-X","article-title":"Mechanisms of rabies virus neutralization by glycoprotein-specific monoclonal antibodies","volume":"161","author":"Dietzschold","year":"1987","journal-title":"Virology"},{"issue":"2","key":"10.1016\/j.vaccine.2006.12.031_bib30","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.virol.2003.10.018","article-title":"Respiratory syncytial virus escape mutant derived in vitro resists palivizumab prophylaxis in cotton rats","volume":"318","author":"Zhao","year":"2004","journal-title":"Virology"},{"issue":"3","key":"10.1016\/j.vaccine.2006.12.031_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1442-200X.2002.01558.x","article-title":"Prevention of respiratory syncytial virus infections in high-risk infants by monoclonal antibody (palivizumab)","volume":"44","author":"Groothuis","year":"2002","journal-title":"Pediatr Int"},{"issue":"5","key":"10.1016\/j.vaccine.2006.12.031_bib32","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1086\/423213","article-title":"Surveillance of clinical isolates of respiratory syncytial virus for palivizumab (Synagis)-resistant mutants","volume":"190","author":"DeVincenzo","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2006.12.031_bib33","unstructured":"WHO consultation on a rabies monoclonal antibody cocktail for rabies post exposure treatment. Geneva: WHO; 2002."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X06013661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T11:26:27Z","timestamp":1587295587000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X06013661"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":33,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0264410X06013661"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2006.12.031","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.1079760.532674","asserted-by":"object"}]},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}